Dr. James C. Yao on Everolimus in Pancreatic Neuroendocrine Tumors
13 Visualizzazioni
• 07/13/23
0
0
Incorporare
administrator
Iscritti
James C. Yao, MD, discusses the administration of everolimus (Afinitor) for patients with pancreatic neuroendocrine tumors
For more resources and information regarding targeted therapies in cancer: http://targetedhc.com/
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti